Background/Aim The aim of the present study was to evaluate clinical outcomes of radiotherapy-based treatment in patients with previously untreated cervical esophageal squamous cell carcinoma at a single institution. Patients and Methods We retrospectively analyzed consecutive patients who received curative-intent radi...
Atsuto Katano, Hideomi Yamashita· Cancer Diagnosis & Prognosis· 0 citations
The incidence of prostate adenocarcinoma (PCa) increases with age. Stereotactic body radiotherapy (SBRT) is a curative option; however, the evidence in elderly patients remains limited. This single-institution retrospective cohort study included consecutive patients aged ≥80 years with localized PCa treated with defini...
BACKGROUND
Stereotactic body radiotherapy has become an established treatment option for localised prostate cancer. However, real-world evidence from routine clinical practice remains limited, particularly in cohorts that include older patients. We therefore report long-term outcomes and treatment-related adverse event...
Atsuto Katano, Hideomi Yamashita· Journal of Medical Imaging a...· 0 citations
The findings suggest that the 36.25-Gy regimen may be non-inferior to 40 Gy for EFS and may be associated with fewer grade 4 toxicities and better urinary QOL and should be considered hypothesis-generating.
Hideomi Yamashita, Daichi Sugahara, S. Sawayanagi et al.· Clinical and Translational R...· 0 citations
Risk-adapted SBRT with increased fractionation demonstrated encouraging LC while maintaining an acceptable toxicity profile for central and ultracentral lung tumors, however, the risk of severe toxicity remains, requiring careful patient selection and optimized OAR dose constraints.
Akiko Oka, Hideomi Yamashita, Y. Miki et al.· Journal of Radiation Researc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.